GSK-J4 HCl 25mg | ≥99%
CSNpharm
GSK-J4 HCl is selective inhibitor of jumonji H3K27 demethylase. It can attenuate lipopolysaccharide (LPS)-induced proinflammatory cytokine production.
More Information Supplier PageGSK-J4 HCl
Search Results
GSK-J4 HCl 50mg | ≥99%
CSNpharm
GSK-J4 HCl is selective inhibitor of jumonji H3K27 demethylase. It can attenuate lipopolysaccharide (LPS)-induced proinflammatory cytokine production.
More Information Supplier PageGSK-J4 HCl
Cilengitide Trifluoroacetate 1mg | ≥99%
CSNpharm
Cilengitide Trifluoroacetate is a cyclic RGD pentapeptide antagonist of integrins αvβ3, αvβ5 and α5β1.
More Information Supplier PageCilengitide Trifluoroacetate
Cilengitide Trifluoroacetate 5mg | ≥99%
CSNpharm
Cilengitide Trifluoroacetate is a cyclic RGD pentapeptide antagonist of integrins αvβ3, αvβ5 and α5β1.
More Information Supplier PageCilengitide Trifluoroacetate
PNU-74654 100mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654
PNU-74654 50mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654
PNU-74654 5mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654
PNU-74654 10mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654
PNU-74654 25mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654
PNU-74654 250mg | ≥98%
CSNpharm
PNU-74654 is an inhibitor of Wnt/β-catenin pathway with an IC50 of 129.8 μM in NCI-H295 cell.
More Information Supplier PagePNU-74654